Resources

Your reps spend 72 percent of the week not selling.

The field force model has not changed in thirty years. The arithmetic no longer works.

Pharma commercial models are breaking under their own arithmetic. Reps spend roughly 28 percent of the week actually selling, MSLs spend 70 percent of their time on administration rather than science, and the field force cannot scale to cover the launch volume arriving through 2031. This collection covers the economics, the workflow automation that changes them, and what replaces the traditional territory model.

That architecture is not exciting. It is ontology layers, governance scaffolding, MLR workflow design, audit trails, and human in the loop accountability. Boring infrastructure that does not photograph well in an annual report. Foundational work that makes the difference between an AI deployment that ships and one that quietly stalls in pilot for the third year running.

This collection covers the arithmetic breaking the pharma commercial model. Where rep and MSL time actually goes, which field workflows are mature enough to automate now, what replaces the traditional territory model, and how to reach prescribers who will not take a meeting. Written for commercial leaders who have already noticed the numbers do not work.

Key Insights

What the writing is showing.

  • Pharma reps spend 28 percent of the week selling. The other 72 percent goes to CRM entry, internal meetings, admin, scheduling, and research.

  • A fully loaded US pharma rep costs 250,000 to 350,000 dollars per year.

  • 23 new anti-obesity drugs are projected for approval by 2031. A field force can cover roughly one launch at a time.

Read Deeper

Articles in this collection.

A single small teal pill icon on the left of a deep navy background, opposite a tight cluster of 22 pale grey pill icons on the right, illustrating the coverage mismatch

Pharma

23 Obesity Drugs Are Coming By 2031. Your Field Force Can Cover One. Here Is The Math.

23 new obesity drugs are projected to launch by 2031. The average pharma field force can scale to cover maybe one. Here is how pharma actually wins the GLP-1 decade.

Jun 22 · 3 min read

Six small grey gear icons on a deep navy background, arranged in a clean horizontal row, with each gear progressively highlighted in teal from left to right

Pharma, AI

The 6 Pharma Field Force Workflows That Should Already Be Automated in 2026

Pharma reps spend 72% of the week not selling. McKinsey says 75-85% of workflows can now be automated. Here are the 6 field force workflows ready to ship in 2026.

Jun 16 · 3 min read

A row of horizontal grey bars on a soft navy background, each bar progressively shorter from left to right, with a faint teal arc rising back over the top of the rightmost bar suggesting recovery

AI

Pharma Reps Forget Most of Launch Training Within 30 Days. Here Is the L&D System That Fixes It.

Pharma reps forget up to 80% of launch training within 30 days. Here is the spaced-repetition L&D system that fixes it, and what a 30-day pilot looks like in your org.

Jun 12 · 3 min read

A wide grid of small grey dots on a soft navy background, with a small cluster near the top-left highlighted in teal and the remaining majority faded

AI

Your Pharma Has 5,000 Target Doctors and 30 Field Reps. Here Is the Fix.

Your field force can cover 60 to 80 doctors a month. Your brand needs to reach hundreds more. Here is the AI doctor engagement system that closes the gap and the pilot that proves it in 7 days.

Jun 9 · 3 min read

A single empty hotel banquet chair photographed from an angle on a soft grey background, with a faint teal pattern of light on the floor beside it

Pharma, Business

Speaker Programs Are Quietly Dying

Speaker programs have been the backbone of pharma HCP engagement for thirty years. They are now collapsing under three converging pressures at once.

May 27 · 3 min read

A solitary pharmacy counter rendered in soft grey on a white background, with a single teal figure standing behind it surrounded by negative space

Pharma, Business

The Pharmacist Pharma Forgot

Community pharmacists are the most accessed healthcare professional in most markets, the most trusted on medication decisions, and the most under-engaged stakeholder in pharma's commercial strategy.

May 19 · 3 min read

Pie chart abstraction with 70% in grey and 30% in teal, broken further into a smaller half in lighter teal

Pharma, Business

The MSL Productivity Paradox: 70% Admin, 30% Science

Medical Science Liaisons spend 70% of their time on admin. Of the 30% they spend on science, half is rework. Here is the data and the structural cause.

May 7 · 3 min read

Two abstract human figures rendered in grey on a white background, with a single figure highlighted in teal among a much smaller cluster

Pharma, Business

The Field Force Reckoning: Why Pharma Is Cutting 50% of Its Reps by 2028

Pfizer cut 7,500 reps in 2024. Bayer announced 1,500 in early 2026. Sanofi cut 800 in March. The era of the 600-rep field force is ending. Here is what is replacing it.

May 5 · 3 min read

all of grey rectangles representing ignored pharma emails with a single rectangle highlighted in teal

Pharma, AI

Pharma Spends $6.2B on HCP Marketing. 97% Gets Ignored.

Pharma spent 6.2 billion dollars on HCP digital marketing in 2025. 97 percent of it got ignored. Here is the data and what actually works.

Apr 1 · 3 min read

Questions

What people ask about pharma commercial.

Want to talk about how this applies to your organization?

30 minute call. No deck. We will figure out if I can help.